Omeros (OMER) EBT Margin Growth (3y) (2013 - 2022)
Powered by 
Analysis
Omeros (OMER) EBT Margin Growth (3y) (2013 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | -484.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 132.00 |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | 6,691.00 |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | -2,054.00 |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 8,006.00 |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 9,980.00 |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | -5,319.00 |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 31,363.00 |
| 10 | Omeros | 1.38 Bn | 1.38 Bn | 27.73 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | -35,716.00 |
| Mar 31, 2022 | -45,047.00 |
| Dec 31, 2021 | -23,363.00 |
| Sep 30, 2021 | 79,334.00 |
| Jun 30, 2021 | 189,681.00 |
| Mar 31, 2021 | 168,324.00 |
| Dec 31, 2020 | -70,187.00 |
| Sep 30, 2020 | -14,093.00 |
| Jun 30, 2020 | -16,328.00 |
| Mar 31, 2020 | -13.00 |
| Dec 31, 2019 | -22,392.00 |
| Sep 30, 2019 | 7,041.00 |
| Jun 30, 2019 | 7,223.00 |
| Mar 31, 2019 | 16,667.00 |
| Dec 31, 2018 | 17,508.00 |
| Sep 30, 2018 | -25,005.00 |
| Jun 30, 2018 | -154,168.00 |
| Mar 31, 2018 | 294,625.00 |
| Dec 31, 2017 | 1.16 Mn |
| Sep 30, 2017 | 840,890.00 |